Literature DB >> 15504753

Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.

Yoko Honda1, Fumihiko Ushigome, Noriko Koyabu, Satoshi Morimoto, Yukihiro Shoyama, Takeshi Uchiumi, Michihiko Kuwano, Hisakazu Ohtani, Yasufumi Sawada.   

Abstract

We investigated the effects of grapefruit juice (GFJ) and orange juice (OJ) on drug transport by MDR1 P-glycoprotein (P-gp) and multidrug resistance protein 2 (MRP2), which are efflux transporters expressed in human small intestine. We examined the transcellular transport and uptake of [(3)H]vinblastine (VBL) and [(14)C]saquinavir in a human colon carcinoma cell line (Caco-2) and in porcine kidney epithelial cell lines transfected with human MDR1 cDNA and human MRP2 cDNA, LLC-GA5-COL150, and LLC-MRP2, respectively. In Caco-2 cells, the basal-to-apical transports of [(3)H]VBL and [(14)C]saquinavir were greater than those in the opposite direction. The ratio of basal-to-apical transport to apical-to-basal transport of [(3)H]VBL and [(14)C]saquinavir by Caco-2 cells was reduced in the presence of MK571 (MRPs inhibitor), verapamil (P-gp inhibitor), cyclosporin A (inhibitor of both), 50% ethyl acetate extracts of GFJ and OJ, or their components (6',7'-dihydroxybergamottin, bergamottin, tangeretin, hepatomethoxyflavone, and nobiletin). Studies of transport and uptake of [(3)H]VBL and [(14)C]saquinavir with MDR1 and MRP2 transfectants showed that VBL and saquinavir are transported by both P-gp and MRP2. GFJ and OJ components inhibited the transport by MRP2 as well as P-gp. However, their inhibitory potencies for P-gp or MRP2 were substrate-dependent. The present study has revealed that GFJ and OJ interact with not only P-gp but also MRP2, both of which are expressed at apical membranes and limit the apical-to-basal transport of VBL and saquinavir in Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504753      PMCID: PMC1575941          DOI: 10.1038/sj.bjp.0706008

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Inhibition of P-glycoprotein transport function by grapefruit juice psoralen.

Authors:  E J Wang; C N Casciano; R P Clement; W W Johnson
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

2.  Interaction of citrus juices with felodipine and nifedipine.

Authors:  D G Bailey; J D Spence; C Munoz; J M Arnold
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

3.  In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.

Authors:  F P Guengerich; D H Kim
Journal:  Carcinogenesis       Date:  1990-12       Impact factor: 4.944

4.  Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.

Authors:  S Döppenschmitt; P Langguth; C G Regårdh; T B Andersson; C Hilgendorf; H Spahn-Langguth
Journal:  J Pharmacol Exp Ther       Date:  1999-01       Impact factor: 4.030

5.  Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.

Authors:  H Takanaga; A Ohnishi; H Matsuo; Y Sawada
Journal:  Biol Pharm Bull       Date:  1998-10       Impact factor: 2.233

6.  Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2).

Authors:  Gregory C Williams; Angela Liu; Gregory Knipp; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.

Authors:  H Gutmann; G Fricker; J Drewe; M Toeroek; D S Miller
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

8.  Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).

Authors:  Y Tanigawara; N Okamura; M Hirai; M Yasuhara; K Ueda; N Kioka; T Komano; R Hori
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

9.  Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.

Authors:  Maarten T Huisman; Johan W Smit; Kristel M L Crommentuyn; Noam Zelcer; Hugh R Wiltshire; Jos H Beijnen; Alfred H Schinkel
Journal:  AIDS       Date:  2002-11-22       Impact factor: 4.177

10.  Interaction between grapefruit juice and midazolam in humans.

Authors:  H H Kupferschmidt; H R Ha; W H Ziegler; P J Meier; S Krähenbühl
Journal:  Clin Pharmacol Ther       Date:  1995-07       Impact factor: 6.875

View more
  27 in total

Review 1.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

2.  Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis.

Authors:  P Hruz; C Zimmermann; H Gutmann; L Degen; U Beuers; L Terracciano; J Drewe; C Beglinger
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 3.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 4.  Efflux transporters as a novel herbivore countermechanism to plant chemical defenses.

Authors:  Jennifer S Sorensen; M Denise Dearing
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

5.  Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren.

Authors:  Tuija Tapaninen; Pertti J Neuvonen; Mikko Niemi
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 6.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

7.  Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse.

Authors:  Yi Zhu; Jaime D'Agostino; Qing-Yu Zhang
Journal:  Drug Metab Dispos       Date:  2011-02-24       Impact factor: 3.922

8.  Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1.

Authors:  Jörn Lötsch; Sebastian Harder; Martin Stürmer; Hans-Wilhelm Doerr; Gerd Geisslinger; Schlomo Staszewski; Nils von Hentig
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

9.  Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells.

Authors:  Hisakazu Ohtani; Tomomi Ikegawa; Youko Honda; Noriko Kohyama; Satoshi Morimoto; Yukihiro Shoyama; Motoharu Juichi; Mikihiko Naito; Takashi Tsuruo; Yasufumi Sawada
Journal:  Pharm Res       Date:  2007-05-10       Impact factor: 4.200

10.  Inhibitory effect of flavonoids on the efflux of N-acetyl 5-aminosalicylic acid intracellularly formed in Caco-2 cells.

Authors:  Shin Yoshimura; Kentaro Kawano; Ryusuke Matsumura; Narumi Sugihara; Koji Furuno
Journal:  J Biomed Biotechnol       Date:  2009-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.